Form 4: Accuray Inc. Director Robert Kill Acquires 56,603 Restricted Stock Units

Director Robert Kill of Accuray Inc. acquired 56,603 restricted stock units on November 29, 2024, which vest on November 21, 2025.

Summary

• Robert Kill, a director at Accuray Inc., acquired 56,603 restricted stock units (RSUs) on November 29, 2024.
• Each RSU represents the right to receive one share of Accuray's common stock.
• The RSUs will vest 100% on November 21, 2025.
• The transaction was reported in a Form 4 filing with the SEC.

Sentiment

Score: 7

Explanation: The document reflects a standard transaction of a director receiving stock units, which is generally viewed positively as it aligns interests with shareholders. There are no negative implications.

Positives

• The acquisition of restricted stock units by a director can be seen as a positive sign of confidence in the company's future.

Future Outlook

The restricted stock units will vest on November 21, 2025, which will result in the director receiving 56,603 shares of common stock at that time.

Industry Context

This is a standard transaction for a director of a public company, often used as part of compensation packages to align the interests of management with shareholders.

Comparison to Industry Standards

• The granting of restricted stock units to directors is a common practice in publicly traded companies, including those in the medical technology sector like Accuray.
• Companies such as Varian Medical Systems and Elekta also use similar equity-based compensation for their directors and executives.
• The vesting period of approximately one year is also typical for such grants.

Stakeholder Impact

• The acquisition of restricted stock units by a director may be viewed positively by shareholders as it aligns the director's interests with the company's performance.

Key Dates

Keywords

Accuray Inc, Robert Kill, Restricted Stock Units, RSU, Director, SEC Form 4, Beneficial Ownership, Stock Acquisition, Vesting